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Background
Percutaneous coronary intervention (PCI) with stent placement is widely used to achieve revascularization of the myocardium, especially in acute coronary syndrome [1] . There are an increasing number of patients treated with PCI with stent implantation subsequently requiring non-cardiac surgery [2] . The issue of antiaggregation and anticoagulation therapy in the coronary artery patients with stent implantation requiring non-cardiac surgery is controversial [2] . According to the newest ACC/AHA guidelines, bare-metal stent (BMS) or balloon angioplasty is recommended as an optimal solution if surgery is to be performed in 6-12 months time after stent placement [3] . Furthermore, same recommendations were proposed by some authors published in this journal [4] . We present a unique case of a patient with colon carcinoma who suffered from post-operational myocardial infarction due to BMS thrombosis after discontinuation of an antiplatelet therapy and introduction of low-molecular weight heparin prior to colorectal cancer surgery, while the drug eluting stent (DES) remained patent.
Case presentation
We present a case of a 56-year-old male with a positive family history of coronary artery disease and colonic cancer, who was admitted to hospital in 1996, for elective coronarography due to angina pectoris. Significant circular narrowing of proximal left anterior descending artery (LAD) and nonsignificant atherosclerotic changes in other coronary arteries were found. PCI of LADwas performedwithout coronary stent placement. Following this procedure, the patient was asymptomatic with repeatedly negative stress testing. In November 2006, he was again admitted to hospital because of an unstable angina pectoris. Significant stenosis of proximal LAD (in the segment of previous PCI) was found, combined with occlusion of proximal left circumflex artery (LCx) with significant stenosis of firstmarginal branch (OM1).
Primary PCIwith stent implantation was performed. Baremetal stents were placed in a proximal segment of LAD and proximal segment of OM1. In the previously occluded LCx, DES was implanted. After the PCI patient had no chest pain and was discharged from hospital in an excellent condition. Sixmonths later, in the same patient a colorectal carcinoma (Dukes C) was diagnosed and elective operation was planned for May 2007. Because of indicated abdominal surgery a dual antiaggregation therapy (aspirin+ clopidogrel) was discontinued 5 days prior, and low-molecular weight heparin (enoxaparine 0.5 mg/kg) was started as requested by anesthesiologist and attending surgeon. The planned resection of descending colon was preformed successfully and patient was admitted to the surgical intensive care unit (ICU). Five hours after admittance in the ICU a patient developed myocardial infarction with ST segment elevation (STEMI) of the anteroseptal region.Our patientwas admitted to cardiac catheterization laboratory for urgent PCI. He received 600 mg of clopidogrel before procedure, heparin and eptifibatide infusion during and after PCI procedure. Coronary angiography showed a thrombotic occlusion of BMS in proximal LAD and fairly patent DES and other BMS in LCx/OM1 (Fig. 1) . Occluded segment was dilated with a balloon and TIMI III flow was established (Fig. 2) .
Immediately after procedure, patient had chest pain relief and rapid resolution of STsegment elevation, and no signs of a significant hemorrhage. He was discharged from hospital 9 days later on a dual antiplatelet therapy. 
Discussion
An increasing number of patients have history of recent coronary stent implantation and may subsequently require noncardiac surgery [2] . According to some authors a discontinuation of antiplatelet therapy prior to surgery is suggested to prevent major bleeding [5] . This brings to a high risk of in-stent thrombosis resulting in myocardial infarction with catastrophic outcomes in such patients [5] . Since DES have been introduced, they have been proven at least as safe as BMS in the follow-up period up to 12 months, with tremendous improvement in issue of restenosis [6] . However some studies, especially Basket Late Study, showed that late stent thrombosis (resulting in acute myocardial infarction/death) is 2-3 times more frequent among patients who had received DES than among those who had received BMS. It is considered that is mostly due to postponed reendothelisation of DES [7] . Therefore, new ACC, AHA and SCAI 2007th updated guidelines for PCI recommended use of BMS or balloon angioplasty for patients that may need noncardiac surgery within 6-12 months [3] . The same recommendation is preferred by authors published in this journal [4] .
We present a unique case of late bare metal stent thrombosis in a patient operated for colorectal carcinoma, while drug eluting stent remained patent. This case together with other similar which were published [8] , suggests that application of these guidelines is hardly acceptable in patients with an aggressive malignancy. The risk of in-stent thrombosis and myocardial infarction in this group of patients is not only due to whether the stent is BMS or DES, but also because of acute surgical stress, inflammatory response andblood loss with haemodilution [9] . Furthermore, the abbreviated coagulationmechanism in patients with malignancies combined with discontinuation of antiaggregation therapy brings additional risk of stent thrombosis [10] .
We would suggest a development of an applicable strategy for selection of patients with increased risk of in-stent thrombosis in other to reduce potentially catastrophic post-operative complications and to ensure development of optimal therapy protocols in the setting of non-cardiac surgery.
